Article info
PDFReview
Is survival and neurodevelopmental impairment at 2 years of age the gold standard outcome for neonatal studies?
- Correspondence to Professor Neil Marlow, Neonatal Medicine, UCL EGA Institute for Women's Health, 74 Huntley Street, London WC1E 6AU, UK; n.marlow{at}ucl.ac.uk
Citation
Is survival and neurodevelopmental impairment at 2 years of age the gold standard outcome for neonatal studies?
Publication history
- Received July 17, 2014
- Revised September 4, 2014
- Accepted September 10, 2014
- First published October 10, 2014.
Online issue publication
October 26, 2017
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/